BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19644603)

  • 1. [Established anticoagulants in secondary haemostasis--Vitamin K antagonists, heparins].
    Langer E; Ziemer S
    Hamostaseologie; 2009 Aug; 29(3):241-6. PubMed ID: 19644603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring of anticoagulants of secondary haemostasis].
    Schuster B
    Hamostaseologie; 2009 Aug; 29(3):268-73. PubMed ID: 19644600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New anticoagulants for secondary haemostasis--anti IIa inhibitors].
    Nowak G
    Hamostaseologie; 2009 Aug; 29(3):256-9. PubMed ID: 19644604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old and new anticoagulants.
    Harbrecht U
    Hamostaseologie; 2011 Feb; 31(1):21-7. PubMed ID: 21311820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How can we improve long-term anticoagulation?].
    Beck EA
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1495-500. PubMed ID: 4081678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Focus on anticoagulants].
    Montalescot G
    Ann Cardiol Angeiol (Paris); 1991 Dec; 40(10):603-6. PubMed ID: 1781635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Melatonin, methadone, tacrine, vitamin K antagonists and low-molecular-weight heparin].
    Sternon J
    Rev Med Brux; 1996 Sep; 17(4):282-6. PubMed ID: 8927862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticoagulation in cardiac pathologies (except atrial fibrillation)].
    Lefebvre P; Friart A
    Rev Med Brux; 1999 Sep; 20(4):A245-9. PubMed ID: 10523900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging anticoagulants for the treatment of venous thromboembolism.
    Weitz JI
    Thromb Haemost; 2006 Sep; 96(3):274-84. PubMed ID: 16953267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antithrombotic therapy in patients with mechanical valve prostheses].
    Roudaut R; Lorient-Roudaut MF
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1543-50. PubMed ID: 9092416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticoagulation by oral treatment with vitamin K antagonists].
    Kemkes-Matthes B
    Hamostaseologie; 2008 Dec; 28(5):421-7. PubMed ID: 19132171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K deficiency amplifies anticoagulation response to ximelagatran: possible implications for direct thrombin inhibitors and their clinical safety.
    Kamali F; Wood P; Ward A
    Ann Hematol; 2009 Feb; 88(2):141-9. PubMed ID: 18716776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral anticoagulation therapy in children.
    Bonduel MM
    Thromb Res; 2006; 118(1):85-94. PubMed ID: 16709477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.